Effect of Anti-CD303 Antibodies in Autoimmune Diseases
NCT03370627
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
138
Enrollment
OTHER
Sponsor class
Conditions
Immune Disease
Interventions
BIOLOGICAL:
Monoclonal anti-cd303 antibody
Sponsor
University Hospital, Lille
Collaborators
[object Object]